Active ingredientRuboxistaurin HClCat. No. P-R094-001CAS 169939-93-9Family · Pharmaceutical analytical standards
Ruboxistaurin
A protein kinase C beta (PKC beta) inhibitor studied in the 2000s for diabetic retinopathy: in 2006 the US authorities asked for a further clinical trial and the drug was never approved. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The name of its family, bisindolylmaleimides, describes the structure: two indole groups, like the one in tryptophan, attached to a maleimide ring and here closed into a large macrocycle.
Go to the active ingredient →Active ingredientRuboxistaurin HClCat. No. P-R094-001CAS 169939-93-9
Isotopically labelledRuboxistaurin-d6 HClCat. No. P-R094-002CAS 1794767-04-6
ImpurityRuboxistaurin Impurity 1Cat. No. P-R094-003No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.